Incorporating Pharmacological Target-Mediated Drug Disposition (TMDD) in a Whole-Body Physiologically Based Pharmacokinetic (PBPK) Model of Linagliptin in Rat and Scale-up to Human
Nan Wu, Guohua An
Topics & Concepts
PharmacokineticsLinagliptinPhysiologically based pharmacokinetic modellingChemistryPharmacologyDrugDissociation constantEndocrinologyBiochemistryReceptorBiologyType 2 diabetesDiabetes mellitusDiabetes Treatment and ManagementNeuropeptides and Animal PhysiologyReceptor Mechanisms and Signaling